Profile of a Stock Promoter

Somehow enough investors never seem to catch on, so con artists make millions of dollars all the time by convincing investors to contribute money to companies that turn out to be phony. Here’s an entertaining profile of someone who was active as a stock promoter until recently and fleeced investors out of a lot of money. Learn from their mistakes.

Another investor, Croatian investor Bruno Mlinar, who met Nobles when both were in Europe racing Ferraris in 2008, gave Nobles $2.5 million for a stake in Nobles Medical Technology and a new venture, Gyntlecare, after Nobles assured him that his company was going to be worth over $150 million pending some Food and Drug Administration approvals.

Fast forward to 2010, and after what Mlinar claims was more than a year of frustrated calls about not getting stock certificates, he received shares in a company called Nobles Medical Technology II, which he said he had never heard of and hadn’t invested in. He also received $435,000 in cash from one Karen Glassman at Gyntlecare (who also appears listed as a representative of HeartStitch and other Anthony Nobles entities.) The problem is, Mlinar’s suit about the matter asserts, one of the companies he thought he was investing in, Nobles Medical Technology, had been sold to Medtronic for $15 million in 2010 and Mlinar didn’t profit because he was given shares in a different company.